Neovascularization in Human Atherosclerosis
暂无分享,去创建一个
Marc Sirol | Valentin Fuster | V. Fuster | P. Moreno | A. Levy | M. Sirol | Pedro R. Moreno | K-Raman Purushothaman | Andrew P. Levy | K. Purushothaman
[1] D. Haskard,et al. Hemoglobin Scavenger Receptor CD163 Mediates Interleukin-10 Release and Heme Oxygenase-1 Synthesis: Antiinflammatory Monocyte-Macrophage Responses In Vitro, in Resolving Skin Blisters In Vivo, and After Cardiopulmonary Bypass Surgery , 2004, Circulation research.
[2] V. Fuster,et al. Intimomedial Interface Damage and Adventitial Inflammation Is Increased Beneath Disrupted Atherosclerosis in the Aorta: Implications for Plaque Vulnerability , 2002, Circulation.
[3] D. Goeddel,et al. Vascular endothelial growth factor is a secreted angiogenic mitogen. , 1989, Science.
[4] Zahi A Fayad,et al. Atherothrombosis and high-risk plaque: part I: evolving concepts. , 2005, Journal of the American College of Cardiology.
[5] D. Heistad,et al. Vasa Vasorum in Atherosclerotic Coronary Arteries: Responses to Vasoactive Stimuli and Regression of Atherosclerosis , 1988, Circulation research.
[6] I. Vlodavsky,et al. Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis. , 2001, The Journal of clinical investigation.
[7] A. Barger,et al. Hypothesis: vasa vasorum and neovascularization of human coronary arteries. A possible role in the pathophysiology of atherosclerosis. , 1984, The New England journal of medicine.
[8] Ralph Weissleder,et al. Detection of Vascular Adhesion Molecule-1 Expression Using a Novel Multimodal Nanoparticle , 2005, Circulation research.
[9] E. Ritman,et al. Coronary vasa vasorum neovascularization precedes epicardial endothelial dysfunction in experimental hypercholesterolemia. , 2001, Cardiovascular Research.
[10] C. Vlachopoulos,et al. Effect of vasa vasorum flow on structure and function of the aorta in experimental animals. , 1995, Circulation.
[11] Renu Virmani,et al. Intraplaque hemorrhage and progression of coronary atheroma. , 2003, The New England journal of medicine.
[12] A. Levy,et al. Genetically Determined Heterogeneity in Hemoglobin Scavenging and Susceptibility to Diabetic Cardiovascular Disease , 2003, Circulation research.
[13] G. Semenza. Expression of hypoxia-inducible factor 1: mechanisms and consequences. , 2000, Biochemical pharmacology.
[14] A. Kurosky,et al. Haptoglobin: the evolutionary product of duplication, unequal crossing over, and point mutation. , 1982, Advances in human genetics.
[15] Ralph Weissleder,et al. Seeing Within: Molecular Imaging of the Cardiovascular System , 2004, Circulation research.
[16] M. Shibuya,et al. The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions. , 2005, Clinical science.
[17] C. Alpers,et al. Neovascular expression of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in human atherosclerosis and their relation to intimal leukocyte content. , 1996, Circulation.
[18] T. Ohhashi,et al. Effects of aortic pressure and vasoactive agents on the vascular resistance of the vasa vasorum in canine isolated thoracic aorta. , 1992, The Journal of physiology.
[19] Chun Yuan,et al. Quantitative Magnetic Resonance Imaging Analysis of Neovasculature Volume in Carotid Atherosclerotic Plaque , 2003, Circulation.
[20] G. Gibbons,et al. The emerging concept of vascular remodeling. , 1994, The New England journal of medicine.
[21] K. Jablonski,et al. Haptoglobin phenotype is an independent risk factor for cardiovascular disease in individuals with diabetes: The Strong Heart Study. , 2002, Journal of the American College of Cardiology.
[22] S. North,et al. Recent developments in the regulation of the angiogenic switch by cellular stress factors in tumors. , 2005, Cancer letters.
[23] J. Ehrhardt,et al. Regulation of blood flow to the aortic media in dogs. , 1978, The Journal of clinical investigation.
[24] K. Sueishi,et al. Intimal neovascularization in human coronary atherosclerosis: its origin and pathophysiological significance. , 1995, Human pathology.
[25] Mark M. Kockx,et al. Phagocytosis and Macrophage Activation Associated With Hemorrhagic Microvessels in Human Atherosclerosis , 2003, Arteriosclerosis, thrombosis, and vascular biology.
[26] E. Sztul,et al. Experimentally induced changes in the endocytic traffic of P-glycoprotein alter drug resistance of cancer cells. , 1997, The American journal of physiology.
[27] V. Fuster,et al. Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbit. , 1990, The Journal of clinical investigation.
[28] D M Shames,et al. MR imaging characterization of microvessels in experimental breast tumors by using a particulate contrast agent with histopathologic correlation. , 2001, Radiology.
[29] R. Busse,et al. Thrombin Activates the Hypoxia-Inducible Factor-1 Signaling Pathway in Vascular Smooth Muscle Cells: Role of the p22phox-Containing NADPH Oxidase , 2001, Circulation research.
[30] Khawar Gul,et al. Vasa vasorum imaging: A new window to the clinical detection of vulnerable atherosclerotic plaques , 2005, Current atherosclerosis reports.
[31] A. Becker,et al. Leucocyte recruitment in rupture prone regions of lipid-rich plaques: a prominent role for neovascularization? , 1999, Cardiovascular research.
[32] W. Markiewicz,et al. Haptoglobin polymorphism predicts 30-day mortality and heart failure in patients with diabetes and acute myocardial infarction. , 2005, Diabetes.
[33] A. Kastrati,et al. Haptoglobin Genotype Is Predictive of Major Adverse Cardiac Events in the 1-year Period after Percutaneous Transluminal Coronary Angioplasty in Individuals with Diabetes , 2022 .
[34] I. Hochberg,et al. Haptoglobin phenotype and vascular complications in patients with diabetes. , 2000, The New England journal of medicine.
[35] P. Carmeliet. Angiogenesis in health and disease , 2003, Nature Medicine.
[36] E L Ritman,et al. Enhanced coronary vasa vasorum neovascularization in experimental hypercholesterolemia. , 1998, The Journal of clinical investigation.
[37] A. Levy,et al. Structure-function analysis of the antioxidant properties of haptoglobin. , 2001, Blood.
[38] S. Moncada,et al. Rapid development of atherosclerotic lesions in the rabbit carotid artery induced by perivascular manipulation. , 1989, Atherosclerosis.
[39] D. Bates,et al. Vascular endothelial growth factor increases microvascular permeability via a Ca(2+)-dependent pathway. , 1997, The American journal of physiology.
[40] M. Ferguson,et al. Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques. Implications for the mode of progression of advanced coronary atherosclerosis. , 1993, The Journal of clinical investigation.
[41] S. Moestrup,et al. CD163: a signal receptor scavenging haptoglobin-hemoglobin complexes from plasma. , 2002, The international journal of biochemistry & cell biology.
[42] G. Viale,et al. Differentiation between high- and low-grade astrocytoma using a human recombinant antibody to the extra domain-B of fibronectin. , 2002, The American journal of pathology.
[43] M. Bureau,et al. Protective role of interleukin-10 in atherosclerosis. , 1999, Circulation research.
[44] R. Hofer-Warbinek,et al. The Transcription Factor NF-κB and the Regulation of Vascular Cell Function , 2000 .
[45] O. Feron,et al. Innate immunity and angiogenesis. , 2004, Circulation research.
[46] R. Ross,et al. Atherosclerosis is an inflammatory disease. , 1998, American heart journal.
[47] V. Bamm,et al. Haptoglobin phenotypes differ in their ability to inhibit heme transfer from hemoglobin to LDL. , 2004, Biochemistry.
[48] P. Vallance,et al. Endothelin alters the reactivity of vasa vasorum: mechanisms and implications for conduit vessel physiology and pathophysiology , 1999, British journal of pharmacology.
[49] C. Vlachopoulos,et al. Medial necrosis and acute alterations in aortic distensibility following removal of the vasa vasorum of canine ascending aorta. , 1993, Cardiovascular research.
[50] D. Woolley,et al. Neovascularization in early atherosclerotic lesions of human carotid arteries: its potential contribution to plaque development. , 1999, Human pathology.
[51] David Zurakowski,et al. Inhibition of plaque neovascularization reduces macrophage accumulation and progression of advanced atherosclerosis , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[52] S. Feinstein,et al. The powerful microbubble: from bench to bedside, from intravascular indicator to therapeutic delivery system, and beyond. , 2004, American journal of physiology. Heart and circulatory physiology.
[53] S. Grundy,et al. The possible role of the arterial microcirculation in the pathogenesis of atherosclerosis. , 1980, Journal of chronic diseases.
[54] T. Lüscher,et al. Molecular Imaging of Atherosclerotic Plaques Using a Human Antibody Against the Extra-Domain B of Fibronectin , 2004, Circulation research.
[55] H. Dvorak,et al. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. , 1983, Science.
[56] J. Paterson,et al. Hemosiderin deposition in early atherosclerotic plaques. , 1956, A.M.A. archives of pathology.
[57] Circulating endothelial progenitor cells and cardiovascular outcomes. , 2005 .
[58] J. Delanghe,et al. Biological and clinical significance of haptoglobin polymorphism in humans. , 1996, Clinical chemistry.
[59] A. Levy. Haptoglobin: a major susceptibility gene for diabetic cardiovascular disease. , 2004, The Israel Medical Association journal : IMAJ.
[60] W. Risau,et al. Mechanisms of angiogenesis , 1997, Nature.
[61] R. Beelen,et al. Regulation of CD163 on human macrophages: cross‐linking of CD163 induces signaling and activation , 1999, Journal of leukocyte biology.
[62] V. Fuster,et al. High density lipoprotein plasma fractions inhibit aortic fatty streaks in cholesterol-fed rabbits. , 1989, Laboratory investigation; a journal of technical methods and pathology.
[63] L. Tavazzi,et al. Plaque composition in plexogenic and thromboembolic pulmonary hypertension: the critical role of thrombotic material in pultaceous core formation , 2002, Heart.
[64] V. Fuster,et al. New aspects in the pathogenesis of diabetic atherothrombosis. , 2004, Journal of the American College of Cardiology.
[65] M. Brownlee. Biochemistry and molecular cell biology of diabetic complications , 2001, Nature.
[66] J. Isner,et al. Cancer and atherosclerosis: the broad mandate of angiogenesis. , 1999, Circulation.
[67] Yixia Zhang,et al. Immunohistochemical study of intimal microvessels in coronary atherosclerosis. , 1993, The American journal of pathology.
[68] D. Schaer. The macrophage hemoglobin scavenger receptor (CD163) as a genetically determined disease modifying pathway in atherosclerosis. , 2002, Atherosclerosis.
[69] M A Konerding,et al. Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice. , 1999, Circulation.
[70] Samuel A. Wickline,et al. Molecular Imaging of Angiogenesis in Early-Stage Atherosclerosis With &agr;v&bgr;3-Integrin–Targeted Nanoparticles , 2003 .
[71] D. Heistad,et al. Structure and function of vasa vasorum. , 1996, Trends in cardiovascular medicine.
[72] A. Levy,et al. Haptoglobin Genotype– and Diabetes-Dependent Differences in Iron-Mediated Oxidative Stress In Vitro and In Vivo , 2005, Circulation research.
[73] Juan J. Badimon,et al. Plaque Neovascularization Is Increased in Ruptured Atherosclerotic Lesions of Human Aorta: Implications for Plaque Vulnerability , 2004, Circulation.
[74] V. Fuster,et al. Lipid Lowering by Simvastatin Induces Regression of Human Atherosclerotic Lesions: Two Years’ Follow-Up by High-Resolution Noninvasive Magnetic Resonance Imaging , 2002, Circulation.